Important Safety Information Prescribing Information This website is intended for US residents only.
Sancuso Logo

SANCUSO® (granisetron transdermal system)
Contact Us

Customer Service

1-800-SANCUSO (800-726-2876)

(8:00am - 5:30pm ET, Monday-Friday)

Drug Information

1-800-SANCUSO (800-726-2876)

(8:00am - 5:30pm ET, Monday-Friday)

medinfo-us@kyowakirin.com

Patient RX Solutions

www.patientrxsolutions.com

1-800-6-SOLUTIONS (1-800-676-5884)

To report Adverse Drug Events (ADEs)

Phone: 1-800-SANCUSO

(800-726-2876)

E-mail: drugsafety@kyowakirin.com

To report ADEs to the FDA

Phone: 1-800-FDA-1088

www.fda.gov/medwatch

Mailing Address

Kyowa Kirin, Inc.
135 Route 202/206, Suite 6
Bedminster, NJ 07921

Indication and Important Safety Information

Indication

SANCUSO® (granisetron transdermal system) is indicated for the prevention of nausea and vomiting in patients receiving moderately and/or highly emetogenic chemotherapy regimens of up to 5 consecutive days duration.

Important Safety Information

Contraindications

SANCUSO is contraindicated in patients with known hypersensitivity to granisetron or to any of the components of the patch.

Warnings and Precautions

Adverse Reactions

The most common adverse reaction in patients receiving SANCUSO is constipation (5.4%).

To report suspected adverse reactions, contact Kyowa Kirin, Inc. at 1-800-SANCUSO or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

See full Prescribing Information for SANCUSO.